Functional: Neuromodulation: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 168: | Line 168: | ||
***'''<span style="color:#ff0000">May be offered as third-line treatment in a carefully selected patient population, characterized by moderately severe baseline incontinence and frequency and willingness to comply with the PTNS protocol.</span>''' | ***'''<span style="color:#ff0000">May be offered as third-line treatment in a carefully selected patient population, characterized by moderately severe baseline incontinence and frequency and willingness to comply with the PTNS protocol.</span>''' | ||
****Patients must also have the resources to make frequent office visits both during the initial treatment phase and to obtain maintenance treatments in order to achieve and maintain treatment effects. | ****Patients must also have the resources to make frequent office visits both during the initial treatment phase and to obtain maintenance treatments in order to achieve and maintain treatment effects. | ||
**'''FDA-approved for OAB treatment<span style="color:#ff0000">[https://pubmed.ncbi.nlm.nih.gov/31039103/ ★]</span>''' | |||
*<span style="color:#ff0000">'''Adverse events (2):[https://pubmed.ncbi.nlm.nih.gov/31039103/ ★]'''</span> | *<span style="color:#ff0000">'''Adverse events (2):[https://pubmed.ncbi.nlm.nih.gov/31039103/ ★]'''</span> | ||
**<span style="color:#ff0000">'''Painful sensation during stimulation</span>''' that did not interfere with treatment | **<span style="color:#ff0000">'''Painful sensation during stimulation</span>''' that did not interfere with treatment | ||
**<span style="color:#ff0000">'''Minor bleeding at the insertion site'''</span> | **<span style="color:#ff0000">'''Minor bleeding at the insertion site'''</span> | ||
=== Pudendal Nerve === | === Pudendal Nerve === | ||